Author Archive: Tracy Cooley

Tracy Cooley

Tracy serves as the Director of Events Communications and handles all communications for BIO’s events and emerging company policy issues. She loves blogging and podcasting on all things biotech and believes in the great potential of the industry, looking for every opportunity to spread the message far and wide. Nearly everyone in her family is a golfer, and as such, she has what many people have called a “natural” swing. Sometimes she even hits the ball. Tracy just finished her ninth marathon, and has nearly mastered the skill of one-foot-in-front-of-the-other (usually, sometimes the laces get in the way). The joy of her life is her five-year-old daughter Josephine.

Latest Posts

Southward Bound for Partnering for Global Health

I’m heading south – and closer to home – next month.  Join me from March 10-12 in Washington, DC, for our first ever, international Partnering for Global Health Forum. Ok, so technically, I jump on Amtrak in a few hours to go back home to DC, but you get the point! DC in the spring is fabulous – as long as it doesn’t rain. And the conference will be a can’t miss event, even if Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags:

From Fuel to Food to Fashion

Industrial biotech does it all. The Third Wave in biotech is looking bright for the future. Industrial biotech represents the confluence of market demand and the potential for market solution, according to David Berry, MD, PhD of Flagship Ventures – one of the panel speakers. Synthetic biotechnology, for one, is enabling the next generation in biofuels, while companies like Mascoma are commercializing cellulosic ethanol.  The future vision for industrial biotech is to have a significant and Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags:

Mind the Gap: Pharma Chasing Biotech Assets

Validation with big pharma – is it still necessary? Depends on who you talk to. This was one of several questions posed to panelists at today’s business roundtable session. Arguments can be made on both sides, but one thing is for certain, the life sciences financing community has become much more sophisticated in recent years. And biotech and pharma companies have become more sophisticated in doing deals because they have a lot more experience to Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags:

Sen. Brownback to speak at Global Health conference

Global health is the spotlight as BIO teams up with BIO Ventures for Global Health (BVGH) and the Gates Foundation to host the first Partnering for Global Health conference in Washington, D.C.  Kansas Senator Sam Brownback will be a key speaker. This brand new, international event will focus on opportunities for the biotech industry to help accelerate the development of medicines for neglected diseases of the developing world. More info is at http://pgh.bio.org/opencms/PGH/2008/index.jsp  

Events  |  Leave a comment  |  Email This Post
Tags:

The Weather Outside is Frightful

The biggest buzz aside from biotech at the CEO conference is definitely the light snowfall outside.  Word on the street is that it will continue to warm up and the snow won’t stick, hopefully no one’s travel will be dramatically inconvenienced tomorrow. If you want a second opinion: www.weather.com

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: